Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
Oct 13, 2026
$3K Vol.
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
End date: Oct 13, 2026
Outcomes
$16.6B
$211.88 Vol.
59%
59%
$16.8B
$181.63 Vol.
40%
40%
$17B
$118.98 Vol.
33%
33%
$17.2B
$1.96K Vol.
28%
28%
$17.4B
$530.47 Vol.
27%
27%
Rules
This market will resolve to "Yes" if Johnson & Johnson's Innovative Medicine revenue for the upcoming third fiscal quarter, as reported in its official company earnings materials, is above the listed amount. Otherwise, this market will resolve to "No".
Comments
Comments